Latest Regulation News

BCI Minerals reports robust progress in its Mardie Salt and Potash Project, achieving financial close on a $981 million debt facility and advancing construction beyond the halfway mark. The company maintains a strong focus on sustainability and safety as it targets first salt shipment in Q2 FY27.

Burley Minerals has reported robust iron assay results from its Cane Bore Iron Project, significantly enlarging prospective drilling areas and advancing towards a maiden drilling program pending heritage and regulatory approvals.

Bulletin Resources continues its appeal against the refusal of a Native Vegetation Clearing Permit critical to advancing drilling at its Ravensthorpe Lithium Project, while maintaining a strong cash position and reviewing strategic opportunities.

Lakes Blue Energy has responded to ASX concerns over delayed disclosure of director interest changes, attributing the issue to administrative oversights and reaffirming its commitment to compliance.

5G Networks Limited has increased its on-market takeover offer for AuCyber Limited from 11 cents to 13.5 cents per share, marking its final bid ahead of the January 30 deadline.

OncoSil Medical has achieved a key regulatory milestone with MDR certification from BSI, removing post-market restrictions and streamlining its commercial operations across Europe. This approval also paves the way for renewed efforts to enter the Australian market.

OzAurum Resources has made significant strides in its Mulgabbie North Gold Project feasibility study, fully funded by Line Hydrogen Pty Ltd, aiming for a near-term cashflow positive trial operation.

EBR Systems has signed a long-term lease for a 51,000 sq ft facility in Santa Clara, California, positioning itself for significant manufacturing expansion and future growth in wireless cardiac pacing technology.

Viridis Mining & Minerals has cleared major environmental and regulatory hurdles for its Colossus Rare Earth Project, securing critical local government endorsements and submitting comprehensive impact assessments that pave the way for construction in 2026.

Kingfisher Mining has confirmed two new rare earth element lodes and reported exceptional copper assays, bolstering its position in the Gascoyne region amid ongoing strategic diversification.

Zelira Therapeutics has received a fourth funding tranche, bringing total investment to US$3.25 million to support FDA clinical trials of its HOPE® 1 cannabinoid medicine targeting irritability in autism spectrum disorder and Phelan-McDermid Syndrome.

Flagship Investments Limited has released its quarterly report confirming a stable loan-to-value ratio of 19.77% and full compliance with regulatory requirements for the period ending December 2024.